ADAPTIN BIO Trademark

Trademark Overview


On Thursday, September 12, 2024, a trademark application was filed for ADAPTIN BIO with the United States Patent and Trademark Office. The USPTO has given the ADAPTIN BIO trademark a serial number of 98746952. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, March 13, 2025. This trademark is owned by Adaptin Bio, Inc.. The ADAPTIN BIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological preparations for pharmaceuticals; Biological preparations for treatment of cancers, central nervous system diseases and autoimmune disorders; Medical preparations and pharmaceuticals for treatment of cancers, central nervous system diseases and autoimmune disorders; Drug delivery platform technology, namely, drug delivery agents consisting of cellular products that facilitate, enhance or promote optimized delivery of pharmaceutical therapies; Drug delivery agents comprising compounds that facilitate delivery of pharmaceuticals and biotherapeutics; Drug delivery platform comprising of cellular products that facilitate delivery of pharmaceuticals and biotherapeutics; Pharmaceutical preparations for the treatment of cancers, central nervous system diseases and autoimmune disorders using compounds comprising of manipulated immune cells;

Research in the field of biotechnology and pharmaceutical development; Research and development of platform technologies for delivery of therapies; Research and development of platform technologies for delivery of antibody therapies, cell therapies and pharmaceuticals; Research and development regarding the use of immune system cells to discover, research and develop novel platform technologies for delivery of therapies and pharmaceuticals; Pharmaceutical research and development for the treatment of cancers, neurological diseases, and neurological disorders and autoimmune disorders; Scientific research in the field of drug delivery platforms, cell therapies and pharmaceuticals; Pharmaceutical research services; Research and development of pharmaceutical preparations for treatment of cancers, neurological diseases and disorders and autoimmune diseases; Research and development in the fields of pharmaceuticals and biotechnology; Research and development regarding the delivery of drug th...
adaptin bio

General Information


Serial Number98746952
Word MarkADAPTIN BIO
Filing DateThursday, September 12, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateThursday, March 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiological preparations for pharmaceuticals; Biological preparations for treatment of cancers, central nervous system diseases and autoimmune disorders; Medical preparations and pharmaceuticals for treatment of cancers, central nervous system diseases and autoimmune disorders; Drug delivery platform technology, namely, drug delivery agents consisting of cellular products that facilitate, enhance or promote optimized delivery of pharmaceutical therapies; Drug delivery agents comprising compounds that facilitate delivery of pharmaceuticals and biotherapeutics; Drug delivery platform comprising of cellular products that facilitate delivery of pharmaceuticals and biotherapeutics; Pharmaceutical preparations for the treatment of cancers, central nervous system diseases and autoimmune disorders using compounds comprising of manipulated immune cells;
Goods and ServicesResearch in the field of biotechnology and pharmaceutical development; Research and development of platform technologies for delivery of therapies; Research and development of platform technologies for delivery of antibody therapies, cell therapies and pharmaceuticals; Research and development regarding the use of immune system cells to discover, research and develop novel platform technologies for delivery of therapies and pharmaceuticals; Pharmaceutical research and development for the treatment of cancers, neurological diseases, and neurological disorders and autoimmune disorders; Scientific research in the field of drug delivery platforms, cell therapies and pharmaceuticals; Pharmaceutical research services; Research and development of pharmaceutical preparations for treatment of cancers, neurological diseases and disorders and autoimmune diseases; Research and development in the fields of pharmaceuticals and biotechnology; Research and development regarding the delivery of drug therapies across the blood-brain barrier and other physiological barriers; Research and development regarding the delivery of drug and cell therapies to targeted body tissue; Research and development regarding the identification and targeting of specific cells for drug therapies;

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 12, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdaptin Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCharlotte, NC 28277

Trademark Events


Event DateEvent Description
Thursday, September 12, 2024NEW APPLICATION ENTERED
Friday, January 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 13, 2025ASSIGNED TO EXAMINER